Literature DB >> 31983546

A follow-up survey on the reproductive intentions and experiences of women undergoing planned oocyte cryopreservation.

Ahmed Wafi1, Julie Nekkebroeck2, Christophe Blockeel2, Neelke De Munck3, Herman Tournaye2, Michel De Vos4.   

Abstract

RESEARCH QUESTION: What are the current reproductive attitudes and experiences of women who have previously undergone planned oocyte cryopreservation (OoC)?
DESIGN: Retrospective questionnaire-based cohort study involving women who had previously undergone planned OoC between January 2009 and September 2016 at a single centre. Eligible women were contacted via e-mail and invited to complete an anonymous standardized questionnaire that had been developed to evaluate their current relationship status and reproductive situation, their attitudes towards planned OoC and their future reproductive intentions.
RESULTS: Of 460 women who had completed at least one OoC cycle, questionnaires were obtained from 138 women. After a mean (± SD) follow-up of 4.5 ± 2.4 years, two-thirds of respondents (65%) anticipated using their oocytes at some point in the future. The respondents reported an overwhelmingly positive attitude towards planned OoC, with 98% indicating they would recommend this intervention to others. Overall, 83% of respondents were single at the time they requested OoC but only 44% were single at the time they completed the survey. While 43/62 (69%) of women became pregnant after undergoing OoC, the majority 30/43 (70%) of these pregnancies were achieved without using their vitrified oocytes. Finally, 13/28 (46%) who used their cryopreserved oocytes stated that they had achieved a live birth.
CONCLUSIONS: The majority of women who undergo OoC do not regret their experience and many have found a partner in subsequent years. Twenty-one per cent of respondents who attempted to conceive after OoC had a live birth using their cryopreserved oocytes.
Copyright © 2019 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fertility preservation; Follow-up; Planned oocyte cryopreservation; Social freezing

Mesh:

Year:  2019        PMID: 31983546     DOI: 10.1016/j.rbmo.2019.11.010

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  6 in total

1.  Disposition preferences in oocyte preservation patients.

Authors:  Anne P Hutchinson; Shweta Hosakoppal; Kathryn A Trotter; Rafael Confino; John Zhang; Susan C Klock; Angela K Lawson; Mary Ellen Pavone
Journal:  J Assist Reprod Genet       Date:  2022-05-19       Impact factor: 3.357

2.  Clinical outcome of planned oocyte cryopreservation at advanced age.

Authors:  Avi Tsafrir; Ido Ben-Ami; Talia Eldar-Geva; Michael Gal; Nava Dekel; Hadassah Levi; Oshrat Schonberger; Naama Srebnik; Amir Weintraub; Doron Goldberg; Jordana Hyman
Journal:  J Assist Reprod Genet       Date:  2022-10-20       Impact factor: 3.357

3.  Assessing the quality of decision-making for planned oocyte cryopreservation.

Authors:  Samantha Yee; Carly V Goodman; Vivian Fu; Nechama J Lipton; Michal Dviri; Jordana Mashiach; Clifford L Librach
Journal:  J Assist Reprod Genet       Date:  2021-02-11       Impact factor: 3.412

4.  Elective oocyte cryopreservation for age-related fertility decline.

Authors:  E Chronopoulou; C Raperport; A Sfakianakis; G Srivastava; R Homburg
Journal:  J Assist Reprod Genet       Date:  2021-02-19       Impact factor: 3.412

Review 5.  Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation.

Authors:  Zachary Walker; Andrea Lanes; Elizabeth Ginsburg
Journal:  Reprod Biol Endocrinol       Date:  2022-01-07       Impact factor: 5.211

6.  'I feel that injustice is being done to me': a qualitative study of women's viewpoints on the (lack of) reimbursement for social egg freezing.

Authors:  Michiel De Proost; Gily Coene; Julie Nekkebroeck; Veerle Provoost
Journal:  BMC Med Ethics       Date:  2022-03-29       Impact factor: 2.652

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.